Back
Coherus BioSciences Quote, Financials, Valuation and Earnings
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Sell
39
CHRS
Coherus BioSciences
Last Price:
2.04
Seasonality Move:
5.34%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.Coherus BioSciences Price Quote
$2.04
Coherus BioSciences Key Stats
Sell
39
Coherus BioSciences (CHRS)
is a Sell
Day range:
$1.93 - $2.06
52-week range:
$1.43 - $8.22
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.75
P/B ratio:
0%
Volume:
905.3K
Avg. volume:
2.1M
1-year change:
-72.84%
Market cap:
$231.5M
Revenue:
$257.2M
EPS:
$-2.6
How Much Does Coherus BioSciences Make?
-
How Much Are Coherus BioSciences's Sales Annually?
CHRS Revenues are $257.2M -
How Much Profit Does Coherus BioSciences's Make A Year?
CHRS net income is -$237.9M
Is Coherus BioSciences Growing As A Company?
-
What Is Coherus BioSciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.02% -
What Is Coherus BioSciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Coherus BioSciences Stock Price Performance
-
Did Coherus BioSciences Stock Go Up Last Month?
Coherus BioSciences share price went down by -11.3% last month -
Did CHRS's Share Price Rise Over The Last Year?
CHRS share price fell by -72.84% over the past 1 year
What Is Coherus BioSciences 52-Week High & Low?
-
What Is Coherus BioSciences’s 52-Week High Share Price?
Coherus BioSciences has traded as high as $8.22 over the past 52 weeks -
What Is Coherus BioSciences’s 52-Week Low Share Price?
Coherus BioSciences has traded as low as $1.43 over the past 52 weeks
Coherus BioSciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Coherus BioSciences?
-
How Much Debt Does Coherus BioSciences Have?
Total long term debt quarterly is $473.4M -
How Much Cash Does Coherus BioSciences Have?
Cash and short term investments quarterly total is $117.7M -
What Is Coherus BioSciences’s Book Value Per Share?
Book value per share is -1.72
Is Coherus BioSciences Cash Flow Positive?
-
What Is CHRS Cash Flow From Operations?
Cash flow from operations (TTM) is -$174.9M -
What Is Coherus BioSciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $69.6M -
What Is Coherus BioSciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $144.6M
Coherus BioSciences Return On Invested Capital
-
Is Management Doing A Good Job?
CHRS return on invested capital is -77.98% -
What Is Coherus BioSciences Return On Assets?
ROA measures how assets are converting to revenues and is -46.35% -
What Is CHRS Return On Equity?
ROE is a measure of profitability and is 0%
Coherus BioSciences Earnings Date & Stock Price
-
What Is Coherus BioSciences's Stock Price Today?
A single share of CHRS can be purchased today for 2.04 -
What Is Coherus BioSciences’s Stock Symbol?
Coherus BioSciences trades on the nasdaq under the ticker symbol: CHRS -
When Is Coherus BioSciences’s Next Earnings Date?
The next quarterly earnings date for Coherus BioSciences is scheduled on May 8, 2024 -
When Is CHRS's next ex-dividend date?
Coherus BioSciences's next ex-dividend date is April 27, 2024 -
How To Buy Coherus BioSciences Stock?
You can buy Coherus BioSciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Coherus BioSciences Competitors
-
Who Are Coherus BioSciences's Competitors?
Below is a list of companies who compete with Coherus BioSciences or are related in some way:
Coherus BioSciences Dividend Yield
Data Unavailable
Coherus BioSciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -553.24% |
| Revenue: | 101.81% | 1.21% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 7.80 |
| Upside from Last Price: | 282.35% |